{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:18:04Z","timestamp":1770819484818,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2006,9,22]],"date-time":"2006-09-22T00:00:00Z","timestamp":1158883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2006,10,26]]},"DOI":"10.1007\/s00109-006-0099-4","type":"journal-article","created":{"date-parts":[[2006,10,3]],"date-time":"2006-10-03T00:58:25Z","timestamp":1159837105000},"page":"911-918","source":"Crossref","is-referenced-by-count":45,"title":["Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer"],"prefix":"10.1007","volume":"84","author":[{"given":"Rui","family":"Henrique","sequence":"first","affiliation":[]},{"given":"Vera L\u00facia","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Cerveira","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9 Lopes","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Mohammad Obaidul","family":"Hoque","sequence":"additional","affiliation":[]},{"given":"Franclim Ricardo","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Manuel Rodrigues","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"David","family":"Sidransky","sequence":"additional","affiliation":[]},{"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2006,9,22]]},"reference":[{"key":"99_CR1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg R (2000) The hallmarks of cancer. Cell 100:57\u201370","journal-title":"Cell"},{"key":"99_CR2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.med.50.1.401","volume":"50","author":"J Tsihlias","year":"1999","unstructured":"Tsihlias J, Kapusta L, Slingerland J (1999) The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu Rev Med 50:401\u2013423","journal-title":"Annu Rev Med"},{"key":"99_CR3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0955-0674(99)00032-0","volume":"11","author":"P Zhang","year":"1999","unstructured":"Zhang P (1999) The cell cycle and development: redundant roles of cell cycle regulators. Curr Opin Cell Biol 11:655\u2013662","journal-title":"Curr Opin Cell Biol"},{"key":"99_CR4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<194::AID-PATH426>3.0.CO;2-P","volume":"189","author":"Y Takano","year":"1999","unstructured":"Takano Y, Kato Y, Masuda M, Ohshima Y, Okayasu I (1999) Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis. J Pathol 189:194\u2013200","journal-title":"J Pathol"},{"key":"99_CR5","first-page":"2782","volume":"61","author":"E Evron","year":"2001","unstructured":"Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J, Sukumar S (2001) Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res 61:2782\u20132787","journal-title":"Cancer Res"},{"key":"99_CR6","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1002\/j.1460-2075.1994.tb06634.x","volume":"13","author":"AJ Sinclair","year":"1994","unstructured":"Sinclair AJ, Palmero I, Peters G, Farrell PJ (1994) EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein\u2013Barr virus. EMBO J 13:3321\u20133328","journal-title":"EMBO J"},{"key":"99_CR7","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1128\/JVI.69.2.1292-1295.1995","volume":"69","author":"AJ Sinclair","year":"1995","unstructured":"Sinclair AJ, Palmero I, Holder A, Peters G, Farrell PJ (1995) Expression of cyclin D2 in Epstein\u2013Barr virus-positive Burkitt\u2019s lymphoma cell lines is related to methylation status of the gene. J Virol 69:1292\u20131295","journal-title":"J Virol"},{"key":"99_CR8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/384470a0","volume":"384","author":"P Sicinski","year":"1996","unstructured":"Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ, Weinberg RA (1996) Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470\u2013574","journal-title":"Nature"},{"key":"99_CR9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1476-4598-3-33","volume":"3","author":"VS Dhillon","year":"2004","unstructured":"Dhillon VS, Shahid M, Husain SA (2004) CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in granulosa cell tumors (GCTs) of ovarian origin. Mol Cancer 3:33","journal-title":"Mol Cancer"},{"key":"99_CR10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/sj.bjc.6602709","volume":"93","author":"A Mermelshtein","year":"2005","unstructured":"Mermelshtein A, Gerson A, Walfisch S, Delgado B, Shechter-Maor G, Delgado J, Fich A, Gheber L (2005) Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas. Br J Cancer 93:338\u2013345","journal-title":"Br J Cancer"},{"key":"99_CR11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0002-9440(10)64763-3","volume":"156","author":"Y Takano","year":"2000","unstructured":"Takano Y, Kato Y, van Diest PJ, Masuda M, Mitomi H, Okayasu I (2000) Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol 156:585\u2013594","journal-title":"Am J Pathol"},{"key":"99_CR12","first-page":"2127","volume":"8","author":"MF Buckley","year":"1993","unstructured":"Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127\u20132133","journal-title":"Oncogene"},{"key":"99_CR13","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ijc.11508","volume":"107","author":"MJ Fackler","year":"2003","unstructured":"Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S, Argani P (2003) DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and twist in in situ and invasive lobular breast carcinoma. Int J Cancer 107:970\u2013975","journal-title":"Int J Cancer"},{"key":"99_CR14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ijc.11393","volume":"107","author":"A Virmani","year":"2003","unstructured":"Virmani A, Rathi A, Heda S, Sugio K, Lewis C, Tonk V, Takahashi T, Roth JA, Minna JD, Euhus DM, Gazdar AF (2003) Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers. Int J Cancer 107:341\u2013345","journal-title":"Int J Cancer"},{"key":"99_CR15","first-page":"1446","volume":"9","author":"H Matsubayashi","year":"2003","unstructured":"Matsubayashi H, Sato N, Fukushima N, Yeo CJ, Walter KM, Brune K, Sahin F, Hruban RH, Goggins M (2003) Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. Clin Cancer Res 9:1446\u20131452","journal-title":"Clin Cancer Res"},{"key":"99_CR16","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.bjc.6600940","volume":"88","author":"J Yu","year":"2003","unstructured":"Yu J, Leung WK, Ebert MP, Leong RW, Tse PC, Chan MW, Bai AH, To KF, Malfertheiner P, Sung JJ (2003) Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer. Br J Cancer 88:1560\u20131565","journal-title":"Br J Cancer"},{"key":"99_CR17","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","volume":"349","author":"JG Herman","year":"2003","unstructured":"Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042\u20132054","journal-title":"N Engl J Med"},{"key":"99_CR18","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/1078-0432.CCR-03-0643","volume":"10","author":"C Jer\u00f3nimo","year":"2004","unstructured":"Jer\u00f3nimo C, Henrique R, Hoque MO, Ribeiro FR, Oliveira J, Fonseca D, Teixeira MR, Lopes C, Sidransky D (2004) Quantitative RAR\u03b22 hypermethylation: a promising prostate cancer marker. Clin Cancer Res 10:4010\u20134014","journal-title":"Clin Cancer Res"},{"key":"99_CR19","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1158\/1078-0432.CCR-04-0894","volume":"10","author":"C Jer\u00f3nimo","year":"2004","unstructured":"Jer\u00f3nimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, Oliveira J, Teixeira MR, Lopes C, Sidransky D (2004) A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 10:8472\u20138478","journal-title":"Clin Cancer Res"},{"key":"99_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jnci\/dji010","volume":"97","author":"LC Li","year":"2005","unstructured":"Li LC, Carroll PR, Dahiya R (2005) Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Natl Cancer Inst 97:103\u2013115","journal-title":"J Natl Cancer Inst"},{"key":"99_CR21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.eururo.2004.06.014","volume":"46","author":"R Henrique","year":"2004","unstructured":"Henrique R, Jer\u00f3nimo C (2004) Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Eur Urol 46:660\u2013669","journal-title":"Eur Urol"},{"key":"99_CR22","first-page":"4730","volume":"9","author":"A Padar","year":"2003","unstructured":"Padar A, Sathyanarayana UG, Suzuki M, Maruyama R, Hsieh JT, Frenkel EP, Minna JD, Gazdar AF (2003) Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation. Clin Cancer Res 9:4730\u20134734","journal-title":"Clin Cancer Res"},{"key":"99_CR23","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.1158\/1078-0432.CCR-05-1183","volume":"11","author":"E Rosenbaum","year":"2005","unstructured":"Rosenbaum E, Hoque MO, Cohen Y, Zahurak M, Eisenberger MA, Epstein JI, Partin AW, Sidransky D (2005) Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy. Clin Cancer Res 11:8321\u20138325","journal-title":"Clin Cancer Res"},{"key":"99_CR24","first-page":"278","volume-title":"Illustrated guide to the TNM\/pTNM classification of malignant tumors","author":"P Hermanek","year":"1997","unstructured":"Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind C (1997) Prostate. In: Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind C (eds) Illustrated guide to the TNM\/pTNM classification of malignant tumors. Springer, Berlin Heidelberg New York, pp 278\u2013280"},{"key":"99_CR25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/jnci\/91.4.332","volume":"91","author":"SA Ahrendt","year":"1999","unstructured":"Ahrendt SA, Chow JT, Xu L-H, Yang SC, Eisenberger CF, Esteller M, Herman JG, Wi L, Decker PA, Jen J, Sidransky D (1999) Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 91:332\u2013339","journal-title":"J Natl Cancer Inst"},{"key":"99_CR26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0022-5347(17)59889-4","volume":"111","author":"DF Gleason","year":"1974","unstructured":"Gleason DF, Mellinger GT, Veterans Administration Cooperative Urological Research group (1974) Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging. J Urol 111:58\u201364","journal-title":"J Urol"},{"key":"99_CR27","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1158\/1055-9965.EPI-04-0659","volume":"14","author":"R Henrique","year":"2005","unstructured":"Henrique R, Jer\u00f3nimo C, Hoque MO, Carvalho AL, Costa VL, Oliveira J, Teixeira MR, Lopes C, Sidransky D (2005) MT1G hypermethylation is associated with higher tumor stage in prostate cancer. Cancer Epidemiol Biomarkers Prev 14:1274\u20131278","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"99_CR28","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1093\/nar\/24.24.5064","volume":"24","author":"A Olek","year":"1996","unstructured":"Olek A, Oswald J, Walter JA (1996) A modified and improved method of bisulfite based cytosine methylation analysis. Nucleic Acids Res 24:5064\u20135066","journal-title":"Nucleic Acids Res"},{"key":"99_CR29","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1093\/nar\/28.8.e32","volume":"28","author":"CA Eads","year":"2000","unstructured":"Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28:E32","journal-title":"Nucleic Acids Res"},{"key":"99_CR30","first-page":"514","volume":"8","author":"R Maruyama","year":"2002","unstructured":"Maruyama, R, Toyooka S, Toyooka KO, Virmani AK, Zochbauer-Muller S, Farinas AJ, Minna JD, McConnell J, Frenkel EP, Gazdar AF (2002) Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 8:514\u2013519","journal-title":"Clin Cancer Res"},{"key":"99_CR31","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/jnci\/93.22.1747","volume":"93","author":"C Jer\u00f3nimo","year":"2001","unstructured":"Jer\u00f3nimo C, Usadel H, Henrique R, Oliveira J, Lopes C, Nelson WG, Sidransky D (2001) Quantitation of GSTP1 hypermethylation in non-neoplastic prostatic tissue and organ confined prostate adenocarcinoma. J Natl Cancer Inst 93:1747\u20131752","journal-title":"J Natl Cancer Inst"},{"key":"99_CR32","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/MCB.18.6.3163","volume":"18","author":"M Meyyappan","year":"1998","unstructured":"Meyyappan M, Wong H, Hull C, Riabowol KT (1998) Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol Cell Biol 18:3163\u20133172","journal-title":"Mol Cell Biol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-006-0099-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-006-0099-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-006-0099-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T11:24:57Z","timestamp":1587209097000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-006-0099-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,22]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,10,26]]}},"alternative-id":["99"],"URL":"https:\/\/doi.org\/10.1007\/s00109-006-0099-4","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,22]]}}}